Britannica Sources used in this answer

How does basic scientific research help scientists identify targets for new drugs?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Gleevec; imatinib — drug Docking of the anticancer drug Gleevec (imatinib) in the abl domain of the bcr-abl tyrosine kinase. Abnormalities in bcr-abl stimulate the continuous proliferation of bone marrow stem cells, causing an increase in myelogenous cells (granulocytes and macrophages) in the body and leading to chronic myelogenous leukemia (CML).

Basic scientific research is fundamental to drug discovery because it focuses on understanding natural substances and physiological processes rather than immediate product development. By investigating fields such as biochemistry, physiology, and pharmacology, scientists uncover the underlying mechanisms of health and disease.1

These research findings allow scientists to identify potential "targets"—specific biological components whose function can be modulated to treat a condition. These targets may include:1

Receptors
Enzymes
Biological transport processes
Other processes involved in body metabolism

Once a target is identified, researchers can design new drugs or screen existing chemical compounds to interfere with that target's function. For example, in cancer research, understanding the specific molecules involved in tumor growth enables the development of targeted therapies that are often more precise and less toxic than traditional treatments. This transition from basic discovery to targeted intervention is a critical step in modern medicine, ensuring that new drugs are developed based on a rigorous understanding of biological systems.21